Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis

Saudi Medical Journal

Volumn 29, Issue 8, 2008, Pages 1088-1094

  Li, Jun Hua ^a   Zhou, Wei ^a   Liu, Kun ^a   Li, Hong X ^a   Wang, Long ^a  

^a Jingmen No 2 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MELATONIN; MESALAZINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID; CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINA; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; METABOLISM;

ANIMALS; CHEMOKINES; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MELATONIN; RATS; TRINITROBENZENESULFONIC ACID;

EID: 56149118587     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. MacDonald TT, Monteleone G, Pender SL, Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000; 51: 2-9.
2. McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001; 50: 491-495.
3. Sun FF, Lai PS, Yue G, Yin K, Nagele RG, Tong DM, et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001; 25: 33-45.
4. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mocusal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28-35.
5. MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; 4: 54-67.
6. Kristensen NN, Gad M, Thomsen AR, Lu B, Gerard C, Claesson MH. CXC chemokine receptor -3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis. Inflamm Bowel Dis 2006; 12: 374-381.
7. Kwon JH, Keates AC, Anton PM, Botero M, Goldsmith JD, Kelly CP. Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1075-G1083.
8. Hyun JG, Lee G, Brown JB, Grimm GR, Tang Y, Mittal N, et al. Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis 2005; 11: 799-805.
9. Joshi R, Kumar S, Unnikrishnan M, Mukherjee T. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radical Research 2005; 39: 1163-1172.
10. Okawa K, Aoki T, Oiya H, Okuno M. Glucocorticoid treatment of ulcerative colitis. Nippon Rinsho 1999; 57: 2481-2485.
11. Bubenik GA. Gastrointestinal melatonin: Localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.
12. Pentney PT, Bubenik GA. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995; 19: 31-39.
13. Cuzzocrea S, Mazzon E, Serraino I, Lepore V, Terranova ML, Ciccolo A, Caputi AP. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30: 1-12.
14. Mei Q, Yu JP, Xu JM, Wei W, Xiang L, Yue L. Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 2002; 23: 882-886.
15. Morris GP, Beck PL, Herridge MS. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
16. Li JH, Yu JP, Yu HG, Xu XM, Yu LL, Liu SQ. Expression and significance of nuclear factor kappaB p65 in colon tissues of rats with TNBS-induced colitis. World J Gastroenterol 2005; 11: 1759-1763.
17. Yuan GJ, Gong ZJ, Sun XM, Zheng SH, Li X. Tea polyphenols inhibit expressions of iNOS and TNF-alpha and prevent lipopolysaccharide-induced liver injury in rats. Hepatobiliary Pancreat Dis Int 2006; 5: 262-267.
18. Johansson M, Norrgard O, Forsgren S. Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis. Inflamm Bowel Dis 2007; 13: 398-409.
19. Forbes E, Murase T, Yang M, Matthaei KI, Lee JJ, Lee NA, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 2004; 172: 5664-5675.
20. Loftus EV. Microscopic colitis: Epidemiology and treatment. Am J Gastroenterol 2003; 98: S31-S36.
21. Rodrigues M, Zerbini MC, Barbieri D. Immunohistochemical study of colonic mucosa macrophages in children with Crohn>s disease and ulcerative colitis. Arq Gastroenterol 1998; 35: 283-291.
22. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, Kohno S. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002; 49: 678-682.
23. Yang SK, Choi MS, Kim OH, Myung SJ, Jung HY, Hong WS, Kim JH, Min YI. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: Regulations by corticosteroids. Am J Gastroenterol 2002; 97:126-132.
24. Melgar S, Drmotova M, Rehnstrom E, Jansson L, Michaelsson E. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine 2006; 35: 275-283.
25. Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, Schulz P, Weckauf H, Berger I, Otto HF, Meuer SC. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 2002; 441: 500-513.
26. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28-35.
27. Stokman MA, Oude Nijhuis CS, Spijkervet FK, de Bont ES, Dijkstra PU, Daenen SM, et al. The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients. Cancer Invest 2006; 24: 479-483.
28. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: Implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 2004; 242: 409-413.
29. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155: 331-336.
30. Khan WI, Motomura Y, Wang H, El-Sharkawy RT, Verdu EF, Verma-Gandhu M, Rollins BJ, Collins SM. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006; 291: G803-G811.
31. Maestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drug 2001; 10: 467-476
32. Sjoblom M, Jedstedt G, Flemstrom G. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. J Clin Invest 2001; 108: 625-633.
33. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999; 104: 383-389.
34. Rahimi R, Nikfar S, Abdollahi M.Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 2007; 13: PI13-PI18.